These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 36257993)
1. Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges. Falabella M; Minczuk M; Hanna MG; Viscomi C; Pitceathly RDS Nat Rev Neurol; 2022 Nov; 18(11):689-698. PubMed ID: 36257993 [TBL] [Abstract][Full Text] [Related]
2. Leber Hereditary Optic Neuropathy: Bringing the Lab to the Clinic. Rasool N; Lessell S; Cestari DM Semin Ophthalmol; 2016; 31(1-2):107-16. PubMed ID: 26959136 [TBL] [Abstract][Full Text] [Related]
3. Gene therapy for mitochondrial diseases: Leber Hereditary Optic Neuropathy as the first candidate for a clinical trial. Cwerman-Thibault H; Augustin S; Ellouze S; Sahel JA; Corral-Debrinski M C R Biol; 2014 Mar; 337(3):193-206. PubMed ID: 24702846 [TBL] [Abstract][Full Text] [Related]
4. The genetics of leber hereditary optic neuropathy--prototype of an inherited optic neuropathy with mitochondrial dysfunction. Eichhorn-Mulligan K; Cestari DM Semin Ophthalmol; 2008; 23(1):27-37. PubMed ID: 18214789 [TBL] [Abstract][Full Text] [Related]
6. Pathogenic Mitochondria DNA Mutations: Current Detection Tools and Interventions. Mustafa MF; Fakurazi S; Abdullah MA; Maniam S Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32059522 [TBL] [Abstract][Full Text] [Related]
12. Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management. Newman NJ; Yu-Wai-Man P; Biousse V; Carelli V Lancet Neurol; 2023 Feb; 22(2):172-188. PubMed ID: 36155660 [TBL] [Abstract][Full Text] [Related]
13. [Clinical research progress of gene therapy for Leber hereditary optic neuropathy]. Wu YJ; Li WS Zhonghua Yan Ke Za Zhi; 2018 Aug; 54(8):636-640. PubMed ID: 30107658 [TBL] [Abstract][Full Text] [Related]
14. Leber Hereditary Optic Neuropathy: A Mitochondrial Disease Unique in Many Ways. Bi R; Logan I; Yao YG Handb Exp Pharmacol; 2017; 240():309-336. PubMed ID: 27787713 [TBL] [Abstract][Full Text] [Related]
15. Multilocus Mitochondrial Mutations Do Not Directly Affect the Efficacy of Gene Therapy for Leber Hereditary Optic Neuropathy. Yang S; Chen C; Yuan JJ; Wang SS; Wan X; He H; Ma SQ; Li B J Neuroophthalmol; 2020 Mar; 40(1):22-29. PubMed ID: 31246675 [TBL] [Abstract][Full Text] [Related]
16. Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial. Koilkonda RD; Yu H; Chou TH; Feuer WJ; Ruggeri M; Porciatti V; Tse D; Hauswirth WW; Chiodo V; Boye SL; Lewin AS; Neuringer M; Renner L; Guy J JAMA Ophthalmol; 2014 Apr; 132(4):409-20. PubMed ID: 24457989 [TBL] [Abstract][Full Text] [Related]
17. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies. Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727 [TBL] [Abstract][Full Text] [Related]
19. The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy. Zhang Y; Tian Z; Yuan J; Liu C; Liu HL; Ma SQ; Li B Curr Gene Ther; 2017; 17(4):320-326. PubMed ID: 29189152 [TBL] [Abstract][Full Text] [Related]
20. Is there treatment for Leber hereditary optic neuropathy? Peragallo JH; Newman NJ Curr Opin Ophthalmol; 2015 Nov; 26(6):450-7. PubMed ID: 26448041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]